Senate Hearing: mRNA COVID Vaccines and Cancer Link

A U.S. Senate hearing, led by Wisconsin Senator Ron Johnson, has addressed controversial claims regarding mRNA COVID-19 vaccines and their potential association with cancer. The session also investigated allegations of federal health agencies suppressing vaccine safety data and interfering with scientific research.

Key testimony came from Dr. Angus Dalgleish, Professor Emeritus of Oncology at the University of London, who presented observations from his clinical practice. His statements raised significant concerns about post-vaccination health outcomes.

Witness Testimony and Core Allegations

• Senator Ron Johnson chaired the U.S. Senate hearing.
• Dr. Angus Dalgleish, Professor Emeritus of Oncology, provided testimony.
• He reported that six of his melanoma patients experienced relapses after mRNA COVID vaccination.

Dr. Dalgleish noted that these melanoma patients had been in a stable condition for years prior to receiving the mRNA COVID vaccination. Their subsequent relapses prompted concerns about the vaccine’s safety profile.

Mechanisms and Data Integrity Concerns

The hearing, explicitly titled “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications and Research,” focused on specific biological pathways. Discussions centered on the presence of spike proteins in tumors and their potential involvement in cancer development following vaccination.

Beyond the biological claims, the Senate hearing also delved into broader issues impacting public health discourse and scientific integrity. These included serious accusations directed at federal health agencies.

• Allegations that federal health agencies suppressed crucial vaccine safety data.
• Claims of interference by these agencies with independent scientific research.

The proceedings underscore a continued push for transparency and rigorous examination of vaccine safety data, especially concerning long-term health implications like cancer development.